Table 1.
Cancer (n = 376) | Non-Cancer (n = 207) | |
---|---|---|
DASS-21 Depressiona | 4.3 (4.3) | 4.2 (5.0) |
DASS-21 Anxietya | 2.5 (2.8) | 2.8 (3.4) |
Age†a | 58.3 (10.4) | 45.0 (11.7) |
Gender*b | ||
Female | 123 (32.7) | 152 (73.4) |
Male | 253 (67.3) | 55 (26.6) |
Education*b | ||
Less than Bachelor’s degree | 123 (32.7) | 100 (48.3) |
Bachelor’s degree or higher | 253 (67.3) | 107 (51.7) |
Marital status*b | ||
Unmarried | 82 (21.8) | 108 (52.2) |
Married | 294 (78.2) | 99 (47.8) |
Race *b | ||
White, non-Latino | 354 (94.1) | 159 (76.8) |
Non-white | 22 (5.9) | 48 (23.2) |
Cancer siteb | ||
Prostate | 212 (30.9) | --- |
Breast | 57 (8.3) | --- |
Colon/rectal | 51 (7.4) | --- |
Hematologic | 28 (4.1) | --- |
Other | 28 (4.1) | --- |
Cancer stage | ||
Post-tx active monitoringb | 61 (10.5) | --- |
Localized | 143 (24.5) | --- |
Metastatic | 116 (19.9) | --- |
Uncertain about stage | 56 (9.6) | |
Time since diagnosis (years)a | 2.46 (2.80) | --- |
Note.
M (SD);
n (%).
Independent sample t-test or *chi-squared analysis resulted in a significant difference at p < .01 (two-tailed) between groups. Non-cancer participants had no history of cancer.